How reliable are G-protein-coupled receptor antibodies?
Open Access
- 27 January 2009
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 379 (4), 385-388
- https://doi.org/10.1007/s00210-009-0395-y
Abstract
A cluster of manuscripts in this issue of the Journal highlights a lack of selectivity of 49 antibodies against 19 subtypes of alpha(1)- and beta-adrenoceptors, muscarinic, dopamine and galanin receptors as well as vanilloid (TRPV1) receptors. Taken together these data demonstrate that lack of selectivity appears to be the rule rather than the exception for antibodies against G-protein-coupled and perhaps also other receptors. Thus, the previously often applied validation of such antibodies by the disappearance of staining in the presence of blocking peptide, i.e. the antigen against which the antibody was raised, alone is insufficient to demonstrate specificity. We propose that receptor antibodies should be validated by at least one of the following techniques: a) disappearance of staining in knock-out animals of the target receptor, b) reduction of staining upon knock-down approaches such as siRNA treatment, c) selectivity of staining in immunoblots or immunocytochemistry for the target receptor vs. related subtypes when expressed in the same cell line and/or d) antibodies raised against multiple distinct epitopes of a receptor yielding very similar staining patterns. Other issues of consideration to obtain reliable results based on receptor antibodies in applications such as immunohistochemistry or immunoblotting are also being discussed.Keywords
This publication has 28 references indexed in Scilit:
- Lack of Specificity of Commercially Available Antisera: Better Specifications NeededJournal of Histochemistry & Cytochemistry, 2008
- Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2008
- Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout miceNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2007
- Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targetsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Antibodies as Valuable Neuroscience Research Tools versus Reagents of Mass DistractionJournal of Neuroscience, 2006
- 1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overloadJCI Insight, 2006
- Corrigendum: Hawes JJ, Picciotto MR. 2004. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J Comp Neurol 479:410-423.Journal of Comparative Neurology, 2005
- Biochemical and Histochemical Evidence of Nonspecific Binding of α7nAChR Antibodies to Mouse Brain TissueJournal of Histochemistry & Cytochemistry, 2004
- The Glutamate Transporter GLT1a Is Expressed in Excitatory Axon Terminals of Mature Hippocampal NeuronsJournal of Neuroscience, 2004
- Generation, Use, and Validation of Receptor-Selective AntibodiesMethods in molecular biology (Clifton, N.J.), 2003